← All Nanonews

Preliminary results on drug-resistance biomarkers in Leishmania infantum at London Calling 2022

Events 30 May 2022

Poster presentation at London Calling 2022

We presented preliminary results at London Calling 2022, organised by Oxford Nanopore Technologies. The work uses nanopore sequencing to find structural variants in the Leishmania infantum genome and copy-number differences in genes linked to virulence and drug resistance.

The project aims to build a practical platform for sequencing the parasite’s genome, to find biomarkers of pathogenicity and drug resistance and to support molecular epidemiology studies that compare strains from dogs and humans.

Groups that contribute Leishmania infantum isolates or high-molecular-weight DNA can join an international consortium working on better diagnostics.

Questions about this news? Write to info@nano1health.com.